A century of data, some of the most important drugs in modern medicine, and a Wild West of unregulated products being sold online with claims that outrun the evidence. That’s the peptide world right now.

Part of the confusion is that the word "peptide" gets used for everything from injectable insulin — one of the most consequential discoveries in the history of medicine — to vials of powder shipped from overseas with no oversight at all.

In this episode, Dr. Chris Huff pulls the curtain back. He walks through what a peptide actually is (a short chain of amino acids that acts as a signaling molecule in the body), how the story started in the 1920s with insulin, and how the field exploded with GLP-1 agonists like semaglutide— drugs that are reshaping how we think about diabetes, obesity, and even cardiovascular risk.

He gets into the SELECT trial, the roughly 20% relative risk reduction in major cardiovascular events seen with semaglutide in patients with obesity but not diabetes, and what that finding actually means for the people sitting in his exam room.

And he’s just as honest about the other side of the conversation, the wellness side, where peptides like BPC-157, TB-500, CJC-1295, and MOTS-c are marketed for recovery, longevity, and performance.

If someone in your life is considering a peptide — for weightloss, injury recovery, or "longevity" — this episode is worth the listen.

—

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You’re an institution. Time to invest like one.

—

• What a peptide actually is
• How the peptide story started in the 1920s and changed type 1 diabetes from a fatal disease to a manageable one
• How GLP-1 drugs work in the body — insulin, glucagon, gastric emptying, and satiety
• What the SELECT trial showed about semaglutide and cardiovascular risk in patients without diabetes
• The strange but true origin story of GLP-1 medications — and the desert lizard at the center of it
• How approved peptides are actually manufactured, and why that’s different from what you’ll find online
• Why the FDA has issued warnings about unapproved GLP-1 products
• What’s actually known about BPC-157, TB-500, CJC-1295, and MOTS-c — and where the data stops
• The real risks of unregulated peptides, including immune reactions and systemic inflammation
• The questions to ask before starting any peptide therapy

Peptides aren’t good or bad. The right question is whether the specific peptide you’re considering has been studied in humans, manufactured to a standard you can trust, and prescribed by someone who knows your full picture. In medicine, that difference is everything.

Dr. Chris Huff is a cardiologist who’s spent his career trying to make heart health less mysterious. He’s treated thousands of patients, prescribed plenty of medications, talked plenty of patients out of starting them, and brought his own LDL from 170 down into the 60s through nutrition alone. That mix of clinical experience and personal experience shows up in everything he does. He’s a believer in the data. He’s also a believer that the patient in front of him is a whole person, not a lab value.

Work with Dr. Chris Huff: Premier Cardiovascular Health

Facebook: facebook.com/chris.huff.9480

Instagram: @hufcm

Disclaimer: The information provided in this podcast is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making any decisions about your health or medical treatment.

Hundreds of thousands of patients. Decades of data. Some of the strongest evidence in modern medicine. And yet — statins are still one of the most argued-about medications out there.

Why?

Part of it is the internet. Part of it is misunderstanding what these drugs actually do. And part of it is that the conversation almost never matches what really happens in a cardiologist's office.

In this episode, Dr. Chris Huff pulls the curtain back. He talks through how statins came to be (the story starts in a Japanese lab in the 1970s, with a researcher studying fungi), how they work inside the body, and why the real target isn't your cholesterol number — it's the number of particles floating around in your bloodstream looking for a place to land.

He gets honest about the side effects. What's real, what's overblown, and what to do when a statin genuinely isn't working for you.

And he's just as honest about the times he doesn't reach for the prescription pad. Not everyone with elevated cholesterol needs a pill. Sometimes it needs a conversation about food, exercise, and whether you've actually been doing what you said you would.

If you've been told to start a statin and you're not sure — or you're already on one and wondering if you should be — this episode is for you.

—

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You’re an institution. Time to invest like one.

• Where statins actually came from
• Why the cholesterol number on your lab report isn't the whole picture
• What the data really shows regarding heart attack, stroke, and mortality
• Who genuinely needs to be on a statin — and who probably doesn't
• Why people walk in convinced their doctor is just trying to push pills (and the truth about how doctors actually get paid)
• What to do if your muscles ache after starting one
• The alternatives when statins just aren't going to work
• How a calcium score and an Lp(a) test can change the whole conversation

The right answer regarding statin therapy isn't a blanket yes or no. It's a real conversation about your risk, your life, and what you're actually willing to do — and a doctor willing to keep adjusting until it works for you.

Dr. Chris Huff is an interventional cardiologist who's spent his career trying to make heart health less mysterious. He's treated thousands of patients with statins, prescribed plenty, talked plenty out of starting them, and lived the cholesterol journey himself — watching his own LDL climb to 170 in his adulthood and bringing it back down to the 60s through nutrition alone.

That mix of clinical experience and personal experience shows up in everything he does. He's a believer in the data. He's also a believer that the patient in front of him is a whole person, not a lab value.

• The episode on coronary calcium scoring — what it is and why it might change your treatment plan - Episode 42
• Episodes on lowering cholesterol through nutrition — including Dr. Huff's own story - episode - Episode 2
• The deep dive on Lp(a) — the test almost no one is getting - Episode 11

Work with Dr. Chris Huff: Premier Cardiovascular Health

Facebook: facebook.com/chris.huff.9480

Instagram: @hufcm

Disclaimer: The information provided in this podcast is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making any decisions about your health or medical treatment.

Most people think fat is passive — something to lose, shrink, or eliminate.

Dr. Deborah Clegg explains why that mindset is incomplete.

Fat is an active endocrine organ. It produces hormones, regulates metabolism, and directly influences disease risk.

• Why fat distribution matters more than total fat
• The critical difference between visceral and subcutaneous fat
• How estrogen protects metabolic health — and what happens after menopause
• Why women lose weight differently than men
• The role of brown, white, and beige fat in energy balance
• How evolution shaped the way our bodies store fat

This episode challenges the idea that all fat is bad — and reframes it as something to understand, not just fight.

—

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You’re an institution. Time to invest like one.

What You’ll Learn

• The difference between visceral fat (harmful) and subcutaneous fat (protective)
• How estrogen improves metabolic health and fat function
• Why women are protected from metabolic disease before menopause
• What actually happens to body composition after menopause
• Why weight loss is biologically harder for women
• The role of inflammation in unhealthy fat storage
• How brown and beige fat increase calorie burning

Key Takeaway

Not all fat is bad.

Where you store it, how it functions, and how your hormones regulate it matter far more than the number on the scale.

Dr. Deborah J. Clegg is a leading researcher in metabolism, obesity, and cardiometabolic health, with a focus on how sex hormones influence energy balance and fat distribution.

She serves as Vice President for Research at Texas Tech University Health Sciences Center El Paso and has authored more than 150 peer-reviewed publications across nutrition, endocrinology, and metabolic disease.

Originally trained as a dietitian, Dr. Clegg earned her PhD in Nutrition from the University of Georgia, an MBA from Boston University, and completed postdoctoral training in obesity research at the University of Cincinnati.

Her work bridges basic science and clinical insight to better understand — and improve — how we prevent and treat metabolic disease.

Resources & Links

Texas Tech Health Sciences Center (Faculty Page):
https://www.cardiometabolichealth.org/faculty/deborah-j-clegg-phd-mba/

Research & Publications:
Search: Deborah Clegg metabolism research (150+ publications)

Referenced Concepts in Episode:

• Visceral vs subcutaneous fat
• Estrogen and metabolic protection
• Brown & beige fat metabolism
• Hormone replacement therapy (HRT) timing

Episodes Referenced In This Show

#17: From Couch to Everest: Dr. Biff Palmer Discusses His Unlikely Journey to the Top of the World

#22: Why Weight Loss Stalls—Discussing the Role of Hormones, Metabolic Health, and GLP-1 Mimetics with Dr. Marguerite Weston

Work with Dr. Chris Huff: Premier Cardiovascular Health

Facebook: https://www.facebook.com/chris.huff.9480

Instagram: @hufcm

Disclaimer: The information provided in this podcast is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making any decisions about your health or medical treatment.